Beth Kurth

BethKurth1

Vice President & Group Director
Investor Relations & Corporate Communications

 
Summary
Beth is a strategic  communications professional who uses her investor relations and corporate communications expertise to ensure clients optimize interactions with all stakeholders. With a focus on credibility and visibility, Beth is committed to positioning clients for success.

Previous Experience
Beth brings 15+ years of communications expertise across start-ups to established companies, and including the full suite of life and health science sectors – biotech, medtech, digital health, pharma and more.  She provides strategic insight to her clients, helping to differentiate and elevate their market positioning.  Program accomplishments include by-lined articles; thought leadership roundtables; earned media across national, business, local, trade and vertical publications; disease awareness and other videos;  sponsored content; institutional investor  audiences; and more.

Sample Client Representation (past and present)
BioAxone BioSciences Inc
Biotechnology Innovation Organization
Celgene
Iota Bioscience
LeMaitre Vascular
NewLink Genetics
Newron Pharmaceuticals SpA
Origenis
Stericycle
Teva Pharmaceuticals
Torreya Insights

Education
Master of Business Administration, Boston University Questrom School of Business, Boston, MA

Bachelor of Arts in English, Tulane University, New Orleans, LA

Interests
Finance, literature, politics, science and Boston sports teams

Organizations
Boston Women in Finance
Financial Executives International
National Investor Relations Institute

Phone: 617-374-8800 x106